Phase 3
Lung Transplant
Intervention Type:
Inhaled Drug
Funder Type:
Organization | University

Drug Details

iNO stands for Inhaled Nitric Oxide. Nitric oxide is a colorless gas that is formed by the oxidation of nitrogen.

Study Purpose

To conduct a clinical investigation to determine if inhaled epoprostenol (VeletriĀ®, iEPO) and inhaled nitric oxide (iNO) will have similar impact on outcomes in adult patients undergoing durable LVAD placement, heart transplantation, or lung transplantation 2. to conduct a cost-capture analysis on the expense each drug incurs per patient.

This drug has no clinical trials actively recruiting patients at this time.